Economic cost of Guillain-Barré syndrome in the United States

Neurology

Volumn 71, Issue 1, 2008, Pages 21-27

  Frenzen, P D ^a  

^a ECONOMIC RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; GUILLAIN BARRE SYNDROME; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; MORTALITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; TELEPHONE; UNITED STATES; ABSENTEEISM; AMBULATORY CARE; ECONOMICS; HEALTH CARE COST; HEALTH CARE PLANNING; HOSPITALIZATION; LIFE EXPECTANCY; MEDICAL LEAVE; MIDDLE AGED; NURSING; PHYSIOTHERAPY; PRODUCTIVITY; STATISTICS;

ABSENTEEISM; ADULT; AGED; AMBULATORY CARE; COST OF ILLNESS; EFFICIENCY; EMPLOYER HEALTH COSTS; GUILLAIN-BARRE SYNDROME; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; LIFE EXPECTANCY; MIDDLE AGED; MORTALITY; PHYSICAL THERAPY (SPECIALTY); SICK LEAVE; UNITED STATES;

EID: 48249098311     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000316393.54258.d1     Document Type: Article

References (35)

1. Hughes RAC, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-1666.
2. Govoni V, Granieri E. Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol 2001;14:605-613.
3. Bernsen RAJAM, de Jager AEJ, Schmitz PIM, van der Meche FGA. Long-term impact on work and private life after Guillain-Barré syndrome. J Neurol Sci 2002;201: 13-17.
4. Rice DP. Cost of illness studies: what is good about them? Inj Prev 2000;6:177-179.
5. Viscusi WK. The value of risks to life and health. J Econ Lit 1993;31:1912-1946.
6. SAS [computer program]. Version 9.1.3. Cary, NC: SAS Institute, Inc., 2003.
7. Agency for Healthcare Research and Quality, US Department of Health and Human Services. HCUP Healthcare Cost and Utilization Project: NIS Database Documentation. Available at: http://www.hcup-us.ahrq.gov/db/na-tion/nis/ nisdbdocumentation.jsp. Accessed September 12, 2007.
8. Agency for Healthcare Research and Quality, US Department of Health and Human Services. HCUP Healthcare Cost and Utilization Project: Cost-to-Charge Ratio Files. Available at: http://www.hcup-us.ahrq.gov/db/state/cost-tocharge. jsp. Accessed September 12, 2007.
9. Agency for Healthcare Research and Quality, US Department of Health and Human Services. MEPS HC-089: 2004 Full Year Consolidated Data File. Available at: http://www.meps.ahrq.gov/mepsweb/data-stats/ download-data-files-detail.jsp? cboPufNumber = HC-089. Accessed September 12, 2007.
10. Carter GM, Buntin MB, Hayden O, et al. Analyses for the Initial Implementation of the Inpatient Rehabilitation Facility Prospective Payment System. Santa Monica: RAND; 2002. Available at: http://www.rand.org/pubs/ monogra-ph-reports/MR1500/. Accessed November 21, 2007.
11. MedPAC Medicare Payment Advisory Commission. Report to the Congress: New Approaches in Medicare. Washington, DC: MedPAC; 2004.
12. Gage B, Pilkauskas N, Dalton K, et al. Long-Term Care Hospital (LTCH) Payment System Monitoring and Evaluation: Phase II Report. Waltham, MA: RTI International; 2007. Available at: http://www.cms.hhs.gov/ LongTermCareHospitalPPS/02a-RTIReports.asp. Accessed November 21, 2007.
13. Centers for Medicare and Medicaid Services, US Department of Health and Human Services. National Health Expenditure Data. Available at: http://www.cms.hhs.gov/ NationalHealthExpendData/. Accessed September 14, 2007.
14. National Center for Health Statistics, US Department of Health and Human Services. Health, United States, 2006 With Chartbook on Trends in the Health of Americans. Washington: US Government Printing Office; 2006.
15. Centers for Medicare and Medicaid Services, US Department of Health and Human Services. Intermediate Care Facilities for the Mentally Retarded (ICFs/MR). Available at: http://www.cms.hhs.gov/CertificationandComplianc/ 09-ICFMRs.asp. Accessed September 14, 2007.
16. US Department of Veterans Affairs. Fact Sheet: VA Long-Term Care (January 2005). Available at: http:// www1.va.gov/opa/fact/ltcare.asp. Accessed September 14, 2007.
17. World Health Organization. Life Tables for WHO Member States: United States of America - 2004. Available at: http:// www.who.int/whosis/database/ life-tables/life-tables-process. cfm?path=whosis,life-tables&language = english. Accessed November 21, 2007.
18. Forsberg A, de Pedro - Cuesta J, Holmqvist LW. Use of healthcare, patient satisfaction and burden of care in Guillain-Barré syndrome. J Rehabil Med 2006;38:230-236.
19. Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998;339:1797-1802.
20. Bureau of Labor Statistics, US Department of Labor. Current Population Survey, 2005 Annual Social and Economic (ASEC) Supplement. Available at: http:// www.census.gov/apsd/techdoc/cps/cpsmar05.pdf. Accessed September 25, 2007.
21. Bureau of Labor Statistics, US Department of Labor. National Compensation Survey: Compensation Cost Trends. Available at: http://www.bls.gov/ncs/ect/ home.htm. Accessed September 25, 2007.
22. National Center for Health Statistics, US Department of Health and Human Services. Compressed Mortality File. Available at: http://www.cdc.gov/nchs/ products/ elec-prods/subject/mcompres.htm. Accessed September 25, 2007.
23. Mauskopf JA, French MT. Estimating the value of avoiding morbidity and mortality from foodborne illness. Risk Anal 1991;11:619-631.
24. Minino AM, Heron MP, Murphy SL, Kochankek KD. Deaths: final data for 2004. Natl Vital Stat Rep 2007;55: 1-120.
25. RTI International. Cost-of-illness summaries for selected conditions. (January 2006). Available at: http:// www.rti.org/page.cfm?objectid=CA1E1F48- 8B6C-4F07-849D6A4C12CBF3C3. Accessed October 9, 2007.
26. Frenzen PD. Hospital admissions for Guillain-Barré Syndrome in the United States, 1993-2004. Neuroepidemiol-ogy 2007;29:83-88.
27. Buzby JC, Allos BM, Roberts T. The economic burden of Campylobacter-associated Guillain-Barré syndrome. J Infect Dis 1997;176 (suppl 2):S192-S197.
28. Havelaar AH, De Wit MAS, Van Koningsveld R, Van Kempen E. Health burden in the Netherlands due to infection with thermophilic Campylobacter spp. Epidemiol Infect 2000;125:505-522.
29. Esperou H, Jars-Guincestre MC, Bolgert F, Raphael JC, Durand-Zaleski I. Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome. Intensive Care Med 2000;26:1094-1100.
30. Ballesteros M, Lasky T, Nash D, Magder L, Koski CL, Chehrenama M. Guillain-Barré syndrome incidence based on hospital discharge data. J Infect Dis 1998;178: 1228.
31. Food and Drug Administration US. Department of Health and Human Services. 21 CFR Parts 16 and 118. Prevention of Salmonella Enteritidis in shell eggs during production: proposed rule. Fed Regist 2004;69:56823-56906.
32. Nachamkin I, Allos BM, Ho TW. Campylobacter jejuni infection and the association with Guillain-Barré syndrome. In: Nachamkin I, Blaser MJ, eds. Campylobacter, 2nd edition. Washington: ASM Press; 2000;155-175.
33. Taylor BV, Williamson J, Jones D, Coleman D, Luck J, McGregor A. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease. J Clin Neurosci 2007;14:116-121.
34. Taylor BV, Williamson J, Luck J, Coleman D, Jones D, McGregor A. Sensitivity and specificity of serology in determining recent acute Campylobacter infection. Intern MedJ 2004;34:250-258.
35. Tam CC, Rodrigues LC, Petersen I, Islam A, Hayward A, O'Brien SJ. Incidence of Guillain-Barré syndrome among